CYCLOPENTA(4,5)PYRIDO(3,2,1-JK)(1,4)BENZODIAZEPIN-12A(9H)-OL, 4,5,6,7,9A,10,11,12-OCTAHYDRO-, (9AS,12AR)-

[H][C@@]12CCC[C@]1(O)C3=C4N(C2)CCNCC4=CC=C3

InChIKey=RYABTNCLHSGGGV-SWLSCSKDSA-N

InChI=1S/C15H20N2O/c18-15-6-2-4-12(15)10-17-8-7-16-9-11-3-1-5-13(15)14(11)17/h1,3,5,12,16,18H,2,4,6-10H2/t12-,15+/m0/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Substance Class	Chemical Created by `admin` on `Sat Dec 16 15:54:56 UTC 2023` Edited by `admin` on `Sat Dec 16 15:54:56 UTC 2023`
Record UNII	3UE71NM99A
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

CYCLOPENTA(4,5)PYRIDO(3,2,1-JK)(1,4)BENZODIAZEPIN-12A(9H)-OL, 4,5,6,7,9A,10,11,12-OCTAHYDRO-, (9AS,12AR)-

Systematic Name

English

VABICASERIN METABOLITE P4

Common Name

English

Code System Code Type Description

CAS

2304452-55-7

Created by admin on Sat Dec 16 15:54:56 UTC 2023 , Edited by admin on Sat Dec 16 15:54:56 UTC 2023

PRIMARY

FDA UNII

3UE71NM99A

Created by admin on Sat Dec 16 15:54:56 UTC 2023 , Edited by admin on Sat Dec 16 15:54:56 UTC 2023

PRIMARY

PUBCHEM

154572823

Created by admin on Sat Dec 16 15:54:56 UTC 2023 , Edited by admin on Sat Dec 16 15:54:56 UTC 2023

PRIMARY

Related Record Type Details


					WD9550HPNL

PARENT -> METABOLITE

Comments:

IN VITRO

Amount: